Electrochemotherapy in Pets with Cancer
Author Information
Author(s): Enrico P Spugnini, Feliciano Baldi, Pasquale Mellone, Florinda Feroce, Alfredo D'Avino, Francesco Bonetto, Bruno Vincenzi, Gennaro Citro, Alfonso Baldi
Primary Institution: Regina Elena Cancer Institute, Rome, Italy
Hypothesis
Canine and feline cancer patients treated with electrochemotherapy will show patterns of tumor response that can inform treatment standardization for both pets and humans.
Conclusion
Electrochemotherapy significantly increases necrosis and apoptosis in tumors, correlating with longer survival in treated pets.
Supporting Evidence
- High levels of necrosis and apoptosis after electrochemotherapy correlate with longer survival.
- The study involved a total of 127 pets over a 7-year period.
- Histopathological analysis showed significant tumor response to electrochemotherapy.
Takeaway
This study shows that a special cancer treatment called electrochemotherapy helps pets with tumors live longer by making their tumors shrink.
Methodology
127 companion animals with spontaneous tumors were treated with electrochemotherapy and biopsies were analyzed for histopathological changes.
Potential Biases
Potential bias in histopathological analysis due to the involvement of investigators in treatment and outcome assessment.
Limitations
The study is limited to preclinical data and may not fully translate to human patients.
Participant Demographics
Canine and feline cancer patients with spontaneous tumors.
Statistical Information
P-Value
p<0.0001
Confidence Interval
(0.024 – 0.179)
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website